Clementia Pharmaceuticals Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Montreal Canada (2011)
Status: Acquired by Ipsen (2019)

Organization Overview

First Clinical Trial
2014
NCT02190747
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Clementia Pharmaceuticals Inc.